nanotech glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics | Discover Oncology BOC Nano™ Glutathione Liposomes -

Andreozzi GM, Bignamini AA, Davi G, Palareti G, Matuska J, Holy M,

Claims surrounding BPC-157 benefits derive exclusively from preclinical animal studies, which regulatory bodies do not accept as sufficient evidence for human therapeutic approval

Lozenge may be broken into smaller pieces if lower dosage is desired

10.14336/AD.2018.0503 [DOI] [PMC free article] [PubMed] 156.Tanaka E, Yatsuya H, Uemura M, Murata C, Otsuka R, Toyoshima H, et al

The PTK hydrogel-treated group showed the highest ICRS macroscopic score of 11.3 (the score was 12 for native cartilage), which was 2.9 and 5.7 times that in the PMI hydrogel-treated group and the control group, respectively